Company Profile
Alder BioPharmaceuticals, Inc.
Company Overview
Migraine Prevention is Personal to Us
Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company focused on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies.
Alder was founded in 2004 with a shared vision to go beyond the norm in designing antibodies that were focused on the unmet medical needs of patients. We see our company as a compassionate catalyst for change.
We Understand Migraine
At Alder, we know the physical and emotional toll migraine can take, and in fact, some of our employees experience it themselves. We have leveraged our monoclonal antibody (mAb) expertise to design Eptinezumab, our pivotal-stage mAb that inhibits calcitonin gene-related peptide (CGRP). Eptinezumab is currently in late-stage clinical development and, if approved, will be the first-to-market infusion therapy for migraine prevention.
Benefits
The Foundation
We offer medical, dental and vision insurance, covered at 100% for employees and their dependents, along with flexible spending accounts, life insurance, short- and long-term disability, and opportunities to participate in 401(k) and employee stock option plans. This is combined with generous vacation time (new employees start with three weeks of vacation/year), three weeks of paid leave following the birth or adoption of a child, and paid holidays and sick leave.
The “Extra” Perks
At Alder, we believe that taking care of one’s self – both physically and mentally – enables our employees to feel their best and do their best work. To that end, we offer on-site yoga two times each week, monthly reimbursement for gym membership, a corporate sponsored book club and on-site breakfast options, sandwich bar, ice cream treats, snacks and beverages.